
The objective of this study was to evaluate the clinical safety of intravenous zzso contrast media used in patients who underwent zzso at a single zzso Acute adverse reactions to intravenous zzso contrast media used for zzso at the Princess Margaret Hospital, Hong Kong, zzso from January 1999 to November 2004 were recorded in an zzso log zzso The medical records of patients' demographics were zzso reviewed and the nature, frequency and severity of the adverse reactions were investigated and zzso The zzso of acute adverse reactions to intravenous zzso contrast media was zzso zzso patients with 46 adverse zzso The severity of these adverse reactions were zzso mild, zzso moderate (one patient developed zzso of breath that required oxygen supplementation and intravenous zzso zzso and zzso severe (one patient developed an zzso reaction, but successfully recovered through timely zzso No patients were recorded as having contrast zzso and none died as a result of any adverse zzso Among the 45 patients who developed adverse zzso three patients zzso had prior adverse reactions to zzso contrast media, three zzso had prior reactions to a different zzso contrast agent, one zzso had asthma and nine zzso had a history of zzso zzso Overall, zzso of the adverse reactions were not documented in the final zzso report or the clinical medical zzso zzso contrast media are safe and well tolerated by the vast majority of zzso In our study, the adverse reaction rate zzso and the zzso of severe zzso reaction zzso zzso with those reported in the zzso Although most of the symptoms are mild and zzso these adverse reactions must be accurately documented and zzso 

